Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report.

IN, Micallef; PJ, Stiff; AP, Nademanee; RT, Maziarz; ME, Horwitz; EA, Stadtmauer; JL, Kaufman; JM, McCarty; R, Vargo; PD, Cheverton; M, Struijs; B, Bolwell; JF, DiPersio

doi:10.1016/j.bbmt.2018.01.039

Public

Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report.

Shared by NobleBlocks on Feb 2, 2018 • 12:00 AM UTC

Authors:

Micallef IN

Stiff PJ

Nademanee AP

Abstract

The purpose of this report is to analyze long-term clinical outcomes of patients exposed to plerixafor plus granulocyte colony-stimulating factor (G-CSF) for stem cell mobilization. This was a study of patients with non-Hodgkin lymphoma (NHL; n = 167) and multiple myeloma (MM; n = 163) who were enro...

Subject

Multiple myeloma

Long-term follow-up

Non-hodgkin Lymphoma

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!